Activation of the MAPK/ERK1 pathway has been implicated in influenza A virus production and viral nuclear export of ribonucleoprotein complexes (69). The pathway has also been associated with Ebola virus entry coupled with cellular (glycoprotein-induced) damage and elevated cytokine production (70) (71).